Pedianostics® is developing a rapid, non-invasive test to diagnose the gastrointestinal health of fragile infants for earlier and improved treatment. This revolutionary technology simply uses the baby’s stool, providing better alternative to existing risky medical procedures.
Pedianostics® is a spin-off from the University of California Davis collaborative projects with the Departments of Chemistry and the Milk Bioactives Program. After winning the People's Choice Award at the BigBang! Business Plan Competition in May 2010, the founders have continued their efforts on research and development to validate biomarkers for the diagnostic tests.